Citigroup’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$2 6246
2025
Q4
$2 Buy
+1
New +$2 ﹤0.01% 5932
2021
Q2
Sell
-200
Closed -$2K 6314
2021
Q1
$2K Buy
+200
New +$2.38K ﹤0.01% 6054
2016
Q1
Hold
0
7660
2015
Q4
Hold
0
7770
2015
Q2
Hold
0
7668
2015
Q1
Hold
0
7346
2014
Q4
Hold
0
6975
2014
Q3
Hold
0
6916
2014
Q2
Hold
0
6635
2014
Q1
Hold
0
7141
2013
Q4
Hold
0
7094

Other funds holding NSPR

Citigroup's NSPR Position: Q1 2026 in Review

Citigroup sold out of InspireMD (NSPR) in Q1 2026, closing a stake of 1 share — an estimated $2 sold.

Citigroup first reported a position in NSPR in Q1 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2021. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Citigroup reported no remaining InspireMD position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 1 InspireMD share in Q1 2026, an estimated $2.
  • Citigroup first reported a position in InspireMD in Q1 2021 and held it in 2 quarters.
  • Citigroup's InspireMD position peaked at $2K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.